These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 20001756

  • 21. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
    Duray GZ, Ehrlich JR, Hohnloser SH.
    Curr Opin Cardiol; 2010 Jan; 25(1):53-8. PubMed ID: 19881340
    [Abstract] [Full Text] [Related]

  • 22. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM, Verma A, Talajic M, Nattel S, Dorian P, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Jan; 27(1):47-59. PubMed ID: 21329862
    [Abstract] [Full Text] [Related]

  • 23. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Lewalter T.
    J Am Coll Cardiol; 2010 Mar 09; 55(10):1051-2; author reply 1052-3. PubMed ID: 20202525
    [No Abstract] [Full Text] [Related]

  • 24. Dronedarone: a review of characteristics and clinical data.
    Baroletti S, Catella J, Ehle M, Cheng JW.
    Crit Pathw Cardiol; 2010 Jun 09; 9(2):94-101. PubMed ID: 20520217
    [Abstract] [Full Text] [Related]

  • 25. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
    Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM.
    J Cardiovasc Electrophysiol; 2010 Jun 01; 21(6):597-605. PubMed ID: 20384650
    [Abstract] [Full Text] [Related]

  • 26. Dronedarone: an overview.
    Kozlowski D, Budrejko S, Lip GY, Mikhailidis DP, Rysz J, Raczak G, Banach M.
    Ann Med; 2012 Feb 01; 44(1):60-72. PubMed ID: 21745093
    [Abstract] [Full Text] [Related]

  • 27. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study.
    Davy JM, Herold M, Hoglund C, Timmermans A, Alings A, Radzik D, Van Kempen L, ERATO Study Investigators.
    Am Heart J; 2008 Sep 01; 156(3):527.e1-9. PubMed ID: 18760136
    [Abstract] [Full Text] [Related]

  • 28. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S, Lip GY.
    Expert Rev Cardiovasc Ther; 2009 May 01; 7(5):473-81. PubMed ID: 19419255
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Rosa GM, Bianco D, Parodi A, Valbusa A, Zawaideh C, Bizzarri N, Ferrero S, Brunelli C.
    Expert Opin Drug Metab Toxicol; 2014 Dec 01; 10(12):1751-64. PubMed ID: 25349898
    [Abstract] [Full Text] [Related]

  • 30. Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
    Thind M, Crijns HJ, Naccarelli GV, Reiffel JA, Corp Dit Genti V, Wieloch M, Koren A, Kowey PR.
    J Cardiovasc Electrophysiol; 2020 May 01; 31(5):1022-1030. PubMed ID: 32083368
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of dronedarone on clinical outcomes in patients with lone atrial fibrillation: pooled post hoc analysis from the ATHENA/EURIDIS/ADONIS studies.
    Duray GZ, Torp-Pedersen C, Connolly SJ, Hohnloser SH.
    J Cardiovasc Electrophysiol; 2011 Jul 01; 22(7):770-6. PubMed ID: 21288278
    [Abstract] [Full Text] [Related]

  • 34. The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS.
    Naccarelli GV, Kowey PR.
    Curr Cardiol Rev; 2014 Nov 01; 10(4):303-8. PubMed ID: 24821656
    [Abstract] [Full Text] [Related]

  • 35. Dronedarone for atrial fibrillation?
    Drug Ther Bull; 2010 Nov 01; 48(11):126-8. PubMed ID: 21057032
    [Abstract] [Full Text] [Related]

  • 36. Dronedarone in atrial fibrillation: the aftermath of the PALLAS trial.
    Salam AM.
    Expert Rev Cardiovasc Ther; 2012 Nov 01; 10(11):1345-9. PubMed ID: 23244355
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
    Vamos M, Calkins H, Kowey PR, Torp-Pedersen CT, Corp Dit Genti V, Wieloch M, Koren A, Hohnloser SH.
    Clin Cardiol; 2020 Mar 01; 43(3):291-297. PubMed ID: 31872901
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
    Guerra F, Hohnloser SH, Kowey PR, Crijns HJ, Aliot EM, Radzik D, Roy D, Connolly S, Capucci A.
    Clin Cardiol; 2014 Dec 01; 37(12):717-24. PubMed ID: 25470298
    [Abstract] [Full Text] [Related]

  • 39. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.
    Health Technol Assess; 2010 Oct 01; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [Abstract] [Full Text] [Related]

  • 40. Dronedarone.
    Tamargo J, López-Farré A, Caballero R, Delpón E.
    Drugs Today (Barc); 2011 Feb 01; 47(2):109-33. PubMed ID: 21431100
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.